Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance

Drug Design, Development and Therapy

Volumn 11, Issue , 2017, Pages 659-668

  Su, Yongsheng ^a   Hu, Jian ^a   Huang, Zhibin ^a   Huang, Yubin ^a   Peng, Bingsheng ^a   Xie, Ni ^b   Liu, Hui ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Drug delivery; Enhanced therapeutic effects; Malignant melanoma; Nanoparticles; Paclitaxel

Indexed keywords

CHOLIC ACID; COPOLYMER; COUMARIN; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; TOCOFERSOLAN; ANTINEOPLASTIC AGENT; DRUG CARRIER; POLYMER;

A875 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DRUG RELEASE; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MELANOMA; MELANOMA CELL LINE; MOUSE; MTT ASSAY; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VOLUME; ZETA POTENTIAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; MULTIDRUG RESISTANCE; PATHOLOGY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MELANOMA; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 85014971678     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S127328     Document Type: Article

References (48)

1. Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials. 2011;32(25):5934–5944.
2. Kundranda MN, Niu J. Albumin-bound paclitaxel in solid tumors: clinical development and future directions. Drug Des Devel Ther. 2015;9:3767–3777.
3. Ruttala HB, Ko YT. Liposomal co-delivery of curcumin and albumin/ paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf B Biointerfaces. 2015;128:419–426.
4. Xiong W, Peng L, Chen H, Li Q. Surface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapy. Int J Nanomedicine. 2015;10:2985–2996.
5. Kannan V, Balabathula P, Thoma LA, Wood GC. Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization. J Liposome Res. 2015;25(4):270–278.
6. Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials. 2014;35(7):2391–2400.
7. Balata GF, Essa EA, Shamardl HA, Zaidan SH, Abourehab MA. Self-emulsifying drug delivery systems as a tool to improve solubility and bio-availability of resveratrol. Drug Des Devel Ther. 2016;10:117–128.
8. Su Y, Liu H, Wang J, Lin B, Miao Y, Hu Z. Antimicrobial peptide lysozyme has the potential to promote mouse hair follicle growth in vitro. Acta Histochem. 2015;117(8):798–802.
9. Zeng X, Tao W, Mei L, Huang L, Tan C, Feng SS. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials. 2013;34(25):6058–6067.
10. Chang D, Gao Y, Wang L, et al. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. J Colloid Interface Sci. 2016;463:279–287.
11. Barba AA, Dalmoro A, d’Amore M, Vascello C, Lamberti G. Bio-compatible nano-micro-particles by solvent evaporation from multiple emulsions technique. J Mater Sci. 2014;49(14):5160–5170.
12. Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice. Int J Nanomedicine. 2016; 11:885–904.
13. Battogtokh G, Ko YT. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel. J Drug Target. 2014;22(9):813–821.
14. Herranz-Blanco B, Shahbazi MA, Correia AR, et al. Targeted cancer therapy: pH-switch nanoprecipitation of polymeric nanoparticles for multimodal cancer targeting and intracellular triggered delivery of doxorubicin (Adv. Healthcare Mater. 15/2016). Adv Healthc Mater. 2016;5(15):1834.
15. Razavi M, Nyamathulla S, Karimian H, Noordin MI. Novel swellable polymer of orchidaceae family for gastroretentive drug delivery of famotidine. Drug Des Devel Ther. 2014;8:1315–1329.
16. Totani M, Ando T, Terada K, et al. Utilization of star-shaped polymer architecture in the creation of high-density polymer brush coatings for the prevention of platelet and bacteria adhesion. Biomater Sci. 2014;2(9):1172–1185.
17. Zeng X, Tao W, Mei L, Feng SS. Docetaxel-loaded nanoparticles of dendrimer-like amphiphilic copolymer for cancer therapy. J Control Release. 2015;213:e119.
18. Cuong NV, Hsieh MF, Chen YT, Liau I. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer. J Biomater Sci Polym Ed. 2011;22(11):1409–1426.
19. Ma D, Liu ZH, Zheng QQ, et al. Star-shaped polymer consisting of a porphyrin core and poly(L-lysine) dendron arms: synthesis, drug delivery, and in vitro chemo/photodynamic therapy. Macromol Rapid Commun. 2013;34(6):548–552.
20. Tao W, Zeng X, Zhang J, et al. Synthesis of cholic acid-core poly (ε-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment. Biomater Sci. 2014;2(9):1262–1274.
21. Byeon HJ, Kim I, Choi JS, Lee ES, Shin BS, Youn YS. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy. Int J Nanomedicine. 2015;10:739–748.
22. Gao N, Chen Z, Xiao X, et al. Surface modification of paclitaxel-loaded tri-block copolymer PLGA-b-PEG-b-PLGA nanoparticles with protamine for liver cancer therapy. J Nanopart Res. 2015;17(8):347.
23. Assanhou AG, Li W, Zhang L, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–295.
24. Su YS, Miao Y, Jiang JD, Liu H, Hu J, Hu ZQ. A simple and rapid model for hair-follicle regeneration in the nude mouse. Clin Exp Dermatol. 2015;40(6):653–658.
25. Zhu D, Tao W, Zhang H, et al. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater. 2016;30:144–154.
26. Janvier F, Zhu JX, Armstrong J, Meiselman HJ, Cloutier G. Effects of amphiphilic star-shaped poly(ethylene glycol) polymers with a cholic acid core on human red blood cell aggregation. J Mech Behav Biomed Mater. 2013;18:100–107.
27. Wu Y, Wang Z, Liu G, et al. Novel simvastatin-loaded nanoparticles based on cholic acid-core star-shaped PLGA for breast cancer treatment. J Biomed Nanotechnol. 2015;11(7):1247–1260.
28. Retsas S, Mohith A, Mackenzie H. Taxol and vinorelbine: a new active combination for disseminated malignant melanoma. Anticancer Drugs. 1996;7(2):161–165.
29. Nakahara T, Tamaki Y, Tominaga N, et al. Novel amelanotic and melanotic cell lines NM78-AM and NM78-MM derived from a human oral malignant melanoma. Human Cell. 2010;23(1):15–25.
30. Zeng X, Tao W, Wang Z, et al. Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA-b-TPGS for cancer treatment. Part Part Syst Char. 2015;32(1):112–122.
31. Zhao T, Chen H, Dong Y, et al. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Int J Nanomedicine. 2013;8:1947–1957.
32. Wang T, Zhu D, Liu G, et al. DTX-loaded star-shaped TAPP-PLA-b-TPGS nanoparticles for cancer chemical and photodynamic combination therapy. RSC Adv. 2015;5:50617–50627.
33. Huang L, Chen H, Zheng Y, et al. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Integr Biol (Camb). 2011;3(10):993–1002.
34. Zhang J, Tao W, Chen Y, et al. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. J Mater Sci Mater Med. 2015;26(4):165.
35. Cao W, Zeng X, Liu G, et al. Porphine functionalized nanoparticles of star-shaped poly(ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 1000 succinate biodegradable copolymer for chemophotody-namic therapy on cervical cancer. Acta Biomater. 2015;26:145–158.
36. Tao W, Zeng X, Wu J, et al. Polydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects. Theranostics. 2016;6(4):470–484.
37. Zhang J, Zhao C, Liu Y, Cao L, Wu Y, Huang Q. Size-dependent effect of prochloraz-loaded mPEG-PLGA micro- and nanoparticles. J Nanosci Nanotechnol. 2016;16(6):6231–6237.
38. Wang H, Jia Y, Hu W, Jiang H, Zhang J, Zhang L. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin. Pharm Dev Technol. 2013;18(3):694–700.
39. Ngoune R, Peters A, von Elverfeldt D, Winkler K, Pütz G. Accumulating nanoparticles by EPR: a route of no return. J Control Release. 2016;238:58–70.
40. Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170–183.
41. Guan Q, Sun S, Li X, et al. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. J Mater Sci Mater Med. 2016;27(2):24.
42. Lian D, Chen Y, Xu G, et al. Delivery of siRNA targeting HIF-1α loaded chitosan modified D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin. RSC Adv. 2016;6(44):37740–37749.
43. Baimark Y. Preparation of surfactant-free linear and star-shaped poly (L-lactide)-b-methoxy polyethylene glycol nanoparticles for drug delivery. J Appl Sci. 2012;12(3):263–270.
44. Zhu Z, Li Y, Li X, et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. J Control Release. 2010;142(3):438–446.
45. Loureiro JA, Gomes B, Fricker G, Coelho MA, Rocha S, Pereira MC. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment. Colloids Surf B Biointerfaces. 2016;145:8–13.
46. Korang-Yeboah M, Gorantla Y, Paulos SA, Sharma P, Chaudhary J, Palaniappan R. Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization. Int J Nanomedicine. 2015;10:4763–4781.
47. Muthu MS, Kutty RV, Luo Z, Xie J, Feng SS. Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 2015;39:234–248.
48. Ishak RA, Osman R. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: in vitro pulmonary deposition and cytotoxicity. Int J Pharm. 2015;485(1–2):249–260.